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1. Introduction 
1.1 Polymorphonuclear neutrophils (PMN) 
Polymorphnuclear neutrophils (PMN) possess a very short half-life in the circulation 
because they constitutively undergo apoptosis (Gasmi et al., 1996; Stringer et al., 1996; 
Moulding et al., 1998). Under certain conditions PMN play an important role in the effectors 
arm of host immune defense through the clearance of immune complexes, the phagocytosis 
of opsonized particles, and the release of inflammatory mediators (Shen et al., 1987; Petroni 
et al., 1988; Lloyd et al., 1992). During the recent years the image of PMN has changed 
considerably. Traditionally considered to be the first line defense against bacterial infection.  
It became increasingly clear that PMN also participate in chronic inflammatory disease and 
regulation of the immune response when appropriately activated (Iking-Konert et al., 2002). 
Persistent Staphylococcus aureus-mediated local infection induces the local activation and 
transdifferentiation of PMN to cells with dendritic-like characteristics (Wagner et al., 2006).   
1.2 Interleukin (IL) 
Interleukin is involved in processes of cell activation, cell differentiation, proliferation and 
cell to cell interactions. Each IL acts on a specific group of cells that express the correct 
receptor for the IL. The same IL can be produced by different cell types and an individual IL 
may act on different cell types, eliciting variable biological responses depending on the 
particular cell and its environment (Bhandari, 2002). 
1.2.1 Interleukin (IL)-2 
IL-2 has been considered to be a lymphocyte-activating and growth-promoting factor, and 
has been widely studied on T cells and NK cells (Waldmann, 1989). Monocytes have been 
reported to express IL-2R and to be activated by IL-2 for tumoricidal activity (Espinoza-
Delgado et al., 1990). Thus far, PMN have not been studied for their interaction with IL-2, 
and their possession of IL-2R is unknown. The direct effect of IL-2 on PMN, especially the 
mechanisms involved in the activation of PMN, is unknown, although the ability of other 
immune cells to respond to IL-2 is well studied. Preliminary studies have shown that PMN 
have the capacity to respond to IL-2 with increased antifungal activity (Djeu et al., 1993). 
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More importantly it have identified that PMN express surface receptors for IL-2, but only IL-
2Rß and not IL-2Rǂ is present (Djeu et al., 1993). 
1.2.2 Interleukin (IL)-4 
IL-4 production has been found to occur in thymocytes, mature T-cells, certain malignant T-
cells, mast-cells and basophiles and occasionally, in transformed B-cells (Holter, 1997). It has 
an effect on B-cells, T-cells, monocytes, mast-cells, endothelial cells, and fibroblasts (Paul, 
1991). Directly and/or indirectly, IL-2 has a prominent role in the regulation of IL-4 
producing cells (Holter, 1997). IL-4 binds to a high-affinity cell-surface receptor (IL-4R) to 
exert its effects (Idzerda et al., 1990). It promotes the growth and differentiation of activated 
human B-lymphocytes and shares many biological functions with IL-13 (Aversa et al., 1993). 
1.2.3 Interleukin (IL)-15 
IL-15 is a pleiotropic cytokine which shares biological activities with IL-2. IL-15 uses both ǃ- 
and Ǆ-chains of the IL-2 receptor for binding and signaling. The IL-15 receptor (IL-15R) 
complex also includes a specific ǂ subunit ( IL-15Rǂ) , distinct from the IL-2Rǂ chain. IL-15R 
is expressed on various cells of the immune response, including T- and B-cells, NK cells and 
more recently, peripheral blood neutrophils (Girard et al., 1999). 
IL-15 plays an important role in both innate and adaptive immunity. It induces T-cell 
proliferation and cytokine production, stimulates the locomotion and chemotaxis of T-cells 
and delays its apoptosis. IL-15 has been shown to stimulate the growth and cytotoxicity of 
NK cells and to induce antibody-dependent cell-mediated cytotoxicity. It was also 
demonstrated that this cytokine induces macrophages function and B-cell proliferation 
(Girard et al., 1999). Recent investigation has shown that IL-15 potentiated several 
antimicrobial functions of normal PMN involved in the innate immune response against 
invading pathogens (Casatella  and McDonald, 2000). IL-15 was observed to enhance 
phagocytosis, NF-ќB activation, and IL-8 production and to delay apoptosis of these cells. In 
addition, IL-15 has been shown to prime the metabolic burst of PMN in response to N-
formyl-methionyl-eucyl- phenylalanine (fMLP) (Casatella and McDonald, 2000; Girard et al., 
1996; McDonald et al., 1998; Mastroianni et al., 2000). 
The main source of IL-15 are macrophages / monocytes and lymphocytes as well as 
neutrophils (Casatella and McDonald, 2000; Muro and Taha, 2001; Zissel and Baumer, 2000). 
1.3 Human leukocyte antigen (HLA) class II 
For surface molecules, there are several reports that PMN from a variety of species can 
express HLA class II (Vachiery et al., 1999; Radsak et al., 2000; Iking-Konert et al., 2001a; 
Iking-Konert et al., 2002; Tyler et al., 2006). Under certain stimulation murine neutrophils 
present Class II restricted antigen (Shauna et al., 2008). Coexpression of HLA class II would 
potentially endow PMN with the capacity to influence the adaptive immune system through 
antigen presentation. Previous investigations with mouse, human, and goat PMN defined 
conditions whereby HLA class II expression was observed following stimulation with IFN-
Ǆ, granulocyte macrophage-colony stimulating factor (GM-CSF), or IL-3 (Gosselin et al., 
1993; Smith et al., 1995; Mudzinski et al., 1995; Reinisch et al., 1996) or in human patients, 
www.intechopen.com
 
Human Leukocyte Antigen Class II in Stimulated Polymorphnuclear Neutrophils 
 
57 
with Wegener’s granulomatosis (Haensch et al., 1999; Iking-Konert et al., 2001b). In some 
cases, PMN expression of HLA II was reported as constitutive (Okuda et al., 1979; Vachiery 
et al., 1999), and human PMN were also shown to function as accessory cells for primed T-
cell activation with protein antigens and superantigens (Okuda et al., 1980; Fanger et al., 
1997; Iking-Konert et al., 2001a; Tyler et al., 2006). Bovine PMN expressed detectable levels 
of HLA class II on their surface, only when cocultured with peripheral blood mononuclear 
cells (PBMC). This observation suggested that PMN may up-regulate endogenous HLA 
class II expression or passively acquire HLA class II protein from other leukocytes. 
To better understand the role of IL-2 in the activation of PMN and to explore the possibility 
that the activation of PMN by IL-2 may reflect the interaction between T-cells and PMN. 
These findings provide useful insight for understanding some mechanisms of T-cell and 
PMN interactions and the possible role of PMN in IL-2 immunotherapy. There is evidence 
that HLA class II-positive PMN are able to present the superantigen staphylococcus 
enterotoxin E (SEE) to T-cells in an HLA class II-dependent manner (Fanger et al., 1997). 
Moreover, PMN pulsed with peptide was shown to activate antigen-specific memory T-cells 
(Reali et al., 1996). In addition, PMN stimulated with GM-CSF and IFN-Ǆ has the capacity to 
present antigen to naive T-cells (Fanger et al., 1997). Those PMN with antigen-presenting 
capacity are thought to be a relatively mature population (Mudzinski et al., 1995). There is a 
large production of proinflammatory cytokines from both T-cells and monocytes following 
superantigen activation: T-cells produce IL-1ǃ, IFN-Ǆ, TNF-ǂ, and IL-2 (Jupin et al., 1988; See 
et al., 1992a; Lagoo et al., 1994). While monocytes produce both IL-1ǃ and IFN-Ǆ (See and 
Chow 1992; See et al., 1992; Trede et al., 1994). It has shown that human PMN can be 
induced to express HLA class II molecules both in vitro and in vivo. Specifically, in vitro 
incubation of human PMN from healthy donors with either GM-CSF, IFN-Ǆ, or IL-3 resulted 
in low-level expression of HLA-DR (Gosselin et al., 1993; Smith et al., 1995). In rheumatoid 
arthritis, there is an evidence for T-cells activation, where PMN act as dendritic-like cells at 
the site of inflammation (Iking-Konert et al., 2005).  
1.4 Aim of the study 
The aim of this study was to insure that IL-2, IL-4 or IL- 15 stimulated PMN might be 
involved in T-cell proliferation by acquiring HLA class II antigens. 
2. Materials and methods 
2.1 Immunocytochemistry 
Blood was taken by venous puncture using 7·5 ml heparin-coated tubes (Sarstedt; 
Nümbrecht, Germany) and was analyzed within 2 hours 
The IL-2R of PMN could be detected by immunofluorescence. Freshly isolated PMN by two 
hypotonic/hypertonic lyses steps with 0.2%/1.6% saline were fixed on slides (2 X 105 cells / 
slide) by a cytoSpin 4 centrifuge (Shandon; Frankfurt, Germany) and ice-cold methanol. 
Cells were incubated with 5% goat serum (Sigma; Saint Louis, MO, USA) in PBS followed by 
2 g anti-CD25-FITC (Becton Dickinson; San Jose, USA), 2g anti-CD122-FITC (Serotec; 
Oxford, UK). Anti-mouse IgG-FITC and anti-CD66-FITC (Immunotech. Marseille, France) 
were used as positive and negative control respectively. The slides were examined by 
confocal laser microscopy (Leica, Bensheim, Germany) using Windows TC as software. 
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2.2 Cytofluorometry 
IL-2R was detected on PMN by direct and indirect extracellular fluorescence-activated cell 
sorter (FACS). In direct sets of experiments cells in whole blood were stained with 2μg anti-
CD122-FITC and 2μg anti-CD25 (Serotic; Oxford, UK) as a markers for IL-2Rǃ chain and IL-
2Rǂ chain. Primary an unlabeled antibody for IL-2Rǃ chain was added to cells before 
staining with anti-CD122-FITC.  Anti-mouse IgG-FITC and anti-CD66-FITC (Immunotech.; 
Marseille, France) were used as a negative and a positive control, respectively. 
For HLA class II detection cells in whole blood were double labeled with 2g anti-CD66b-
FITC (Immunotech.; Marseille, France) as a PMN marker and 2g PE-labeled antibodies to 
HLA DP-DQ-DR (Serotec; Oxford, UK), respectively, using standard procedures. They were 
analyzed by FACSCalibur and CellQuest software (Becton-Dickinson, Heidelberg, 
Germany). Results are expressed as percentage of positive cells in the respective gate or 
quadrant. 
2.3 Cells purification and cultivation 
For co-culture, cells were isolated by PolymorphPrep® (Nycomed; Oslo, Norway). PMN, 
Monocytes and T-cells fraction was further purified by adsorption to CD15, CD14 and CD3 
beads (Miltenyi Biotech; Bergisch Gladbach, Germany), respectively, by magnetic cell 
separation using the devices supplied by Milteny Biotech (Bergisch-Gladbach, Germany). 
Highly purified PMN (1 x 106 /ml) were cultivated in AIM V (Gibco BRL; Paisley, 
Scotland)) with 2.5% autologous normal human serum, NHS (inactivated at 56˚C for 30 
min.).  T-cells and monocytes were cultured in RPMI 1640 (Gibco BRL; Paisley, Schottland) 
supplemented with 10% FCS (PAN Biotech GmbH; Aidenbach, Germany), 100U/ml 
penicillin/streptomycin (Gibco BRL; Paisley, Schottland), 2mM L-glutamine (Gibco BRL; 
Paisley, Schottland)), and 10mM HEPES (Gibco BRL; Paisley, Scottland). All the three types 
of cells were incubated at 37C and 5 % CO2 for the times indicated. 
2.4 Stimulation of PMN 
Highly purified PMN were placed into 24-well plate (NuncTm; Roskilde, Danmark)), 
2ml/well, and incubated in the presence or absence of 10ng/ml IL-2 (Sigma; St Louis, MO, 
USA)) for about 48 hours at 37˚C with 5% CO2. 
2.5 RNA isolation and reverse transcription-polymerase chain reaction (RT-PCR) 
Total cellular RNA was isolated using the RNeasy kit from Qiagen (Hilden, Germany). For 
RT, 2 mg of RNA was incubated with 50 pmol random primer, 1 U RNase inhibitor, 10 pmol 
dNTP and 20 U Moloney Murine Leukemia Virus (MMuLV) reverse transcriptase (all 
purchased from Boehringer Mannheim, Germany) for 60 min at 37u, followed by 15 min at 
94u. PCR for HLA class II was carried out in a Perkin-Elmer (UÈ berlingen, Germany) 
thermocycler as follows: 10 pmol dNTP was added to 5 ml of cDNA, followed by 50 pmol of 
the primers and 1 U Taq DNA polymerase in 2 mM MgCl2. After preheating to 94u for 10 
min, 30 cycles for HLA class II were performed (30 seconds at 94u, 30 seconds at 60u,  
60 seconds at 72u) followed by a final extension step at 72u for 10 min. The HLA-DR  
primer was used: sense: 5k-CGGATCCTTCGTGTCCCCAC-3k; antisense: 5k-
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CTCCCCAACCCCGTAGTTGTGTCTGCA-3k, amplifying a 270-bp fragment (Nadler et al., 
1994). This primer were synthesized by ARK Scientific Biosystems (Darmstadt, Germany). 
The PCR products were analyzed by gel electrophoresis (1.5% agarose) and staining with 
Sybr green (Molecular Probes; Leiden, the Netherlands). As a size marker, DNA molecular 
weight marker VI (Boehringer: Mannheim, Germany) was used. For sequencing, the PCR 
product was extracted by using the QIAquick gel extraction kit (Qiagen; Hilden, Germany); 
sequencing was performed using the ABI PRISM2 Big Dye2 Terminator Cycle Sequencing 
Ready Reaction Kit (PE Applied Biosystems; Warrington, UK). Data were measured and 
analyzed by Fluorescent Image Analyzer (FLA)-2000 (Becton Dickinson, San Jose, USA). 
2.6 Coculture expreiments 
Unstimulated and stimulated PMN (1x103) or monocytes (1x10) in 100l were added per 
well of a 96-well concave-bottom plate (Greiner; Nuertingen, Germany). Then, 1x104 T cells 
(100l) were added to each well together with 25ng Staphylococcal aueurs Enterotoxins A 
(Sigma; München, Germany). The effect of IL-2 stimulation was blocked by ant-IL-2R 
(Serotec; Oxford, UK). After coincubation for 4 days at 37C with 5% CO2, proliferation was 
tested by adding 1 mCi of 3H-thymidine (Amer-sham Life Science; Braunschweig, Germany) 
for 6-8 hours [3H]TdR incorporation into DNA was measured and expressed as counts per 
minute (cpm). The values represent the meanSD of 6-12 parallel wells. 
2.7 Statistical analysis 
Data were analyzed by student's t test. And a P value of 0.05 was a considered as the limit of 
significance. 
3. Results 
3.1 Visualization of the IL-2R chain by immunocytochemistry 
Isolated PMN by a hypotonic solution were examined by confocal laser microscopy. The IL-
2R chain was not detectable (Fig. 1c).  However the IL-2R chain was seen in all cells (Fig. 
2c). Mouse IgG-FITC was used as a negative control (Fig. 1a and 2a), while CD66b-FITC was 
used as a positive control (Fig. 1b and 2b), respectively. 
    
Fig. 1. Detection of IL-2R chain on PMN: The negative and positive controls were in panels 
A and B, respectively, while the panel C showed the CD25 (magnification: 1 X 400). 
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Fig. 2. Detection of IL-2R chain on PMN: The negative and positive controls were in panels 
A and B, respectively, while the panel C showed the CD122 (magnification: 1 X400). 
3.2 Direct immunofluorescence analysis of IL-2R 
In order to investigate constitutive expression of IL-2R, we tested the presence of the two IL-
2R chains (IL-2 and IL-2) on the PMN cell surface by FACS. In line with previous data by 
others, the  chain (CD25) could not be detected (< 1 % positive cells), while PMN expressed 
CD122, though rather small amounts (Fig. 3).  
  
    
Fig. 3. Detection of IL-2R on PMN: (A) Forward-scatter (FSC) versus side-scatter (SSC) of 
whole blood flow cytometry showed different populations of leukocytes. R1 was set for 
PMN identified by expression of CD66b (B) filled peak. PMN expressed only IL-2R chain 
(D), while IL-2R chain was absent (C) (filled peaks: antibody; line isotype control).  
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When comparing cells of different donors, the mean fluorescence intensity varied (a 
summary of 6 donors is shown in Table 1). 
 
No. of tested donors Mean fluorescence intensity 
1- 
2- 
3- 
4- 
5- 
6- 
10 
22 
16 
14 
32 
25 
Table 1. Expression IL-2R chain (CD122) on PMN of different donors. 
3.3 Indirect immunofluorescence for the IL-2R chain 
By indirect labeling, using first an unlabeled antibody to IL-2R, followed by a FITC-labeled 
antibody to mouse IgG, the signal for the IL-2R chain could be amplified. Of note is that 
nearly all cells were positive (Fig. 4). 
 
Fig. 4. Indirect extracellular detection of IL-2R chain: (A) the forward-side scatter analysis 
of whole blood flow cytometry showed different populations of leukocytes. PMN were 
identified in R1. (B) M2 is the percentage of CD66b–positive cells (filled peak). (C) PMN 
expressed IL-2R chain as detected by anti-CD122 (filled peak); the line is the negative 
control using mouse IgG in place of anti-CD122. 
3.4 In vitro expression of HLA class II on PMN stimulated with IL-2 
To test effects of IL-2 on HLA class II expression, the induction of HLA class II in highly 
purified PMN 48 hours cultured with IL-2 increased recording 20% (Fig. 5c). Freshly 
isolated PMN had 2% (Fig. 5a). PMN cultured with medium alone for 48 hours had also 
small amount (4%) of HLA class II (Fig. 5b). 
3.5 Effect of IL-2 on HLA class II gene up-regulation on PMN 
In another set of experiments, highly purified PMN exposed to IL-2 for various hours 
showed an increase in HLA class II specific RNA. This was tested by RT-PCR. When the  
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Fig. 5. Direct flow cytometry of the HLA class II induction in highly purified PMN:  
A) Unstimulated PMN (0 hour). B) Unstimulated PMN (48 hours). C) Stimulated PMN with 
IL-2 (48 hours). 
 
  
 
 
Fig. 6. RT-PCR detection of HLA class II mRNA in PMN activated with IL-2: PMN  were 
incubated with IL-2 for 6 hours. The M VI was the used marker (154-2176 bp).  Freshly 
isolated PMN were in Lane (1). Lane (2) showed the stimulated PMN after 6 hours, while 
the unstimulated PMN after 6 hours was in lane (3).  
values were corrected for the input of the PCR-product by using -actin as a housekeeping 
gene (Fig. 6a), it was seen that HLA class II RNA increased only when PMN were cultivated 
for 6 hours. The increase was more pronounced in the presence of IL-2 (Fig. 6b). 
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3.6 In vitro expression of HLA class II on PMN stimulated with IL-4 
The majority of healthy donors PMN expressed CD66b (Fig. 7a, b & c). In the first set of 
experiments the effect of IL-4 on the expression of HLA class II was tested, where we found 
that PMN on whole blood showed expression of HLA class II recording 7.77% (Fig.7c) by 
using IL-4, as stimulators. In contrast, fresh and unstimulated cells cultured with medium 
only counting 1.05% (Fig.7a) and 2.71 % (Fig.7b), respectively. 
 
Fig. 7. Direct flow cytometry of the HLA Class II induction in whole blood PMN.  
A) Unstimulated PMN (0 hour). B) Unstimulated PMN (24 hours). C) Stimulated PMN with 
IL-4 (24 hours).  
3.7 In vitro expression of HLA class II on PMN stimulated with IL-15 
 
 
                           (a)                                                 (b)                                                 (c) 
Fig. 8. Flow cytometric analysis of HLA class II expression on PMN treated with IL-15  
(20ng / ml). PMN in whole blood were labeled with CD66b-FITC as a specific marker for 
PMN and HLA class II-PE. (A) Fresh PMN. (B) PMN cultured for 48hrs in medium. 
(C) PMN cultured for 48hrs in medium with IL-15. 
To test effects of IL-15 on HLA class II expression, in a first set of experiments the induction 
of HLA class II in PMN 24hrs co-cultured with IL-15 was very minor. Although, after 48hrs 
this induction increased recording 11% (Fig. 8c). Freshly PMN had 11% also (Fig. 8a). while 
PMN cultured with medium alone had smaller amout (06%) of HLA class II (Fig. 8b).   
11% 06% 11% 
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3.8 Interaction of HLA class II positive PMN with peripheral T-cells 
The question was addressed, whether PMN stimulated to express HLA class II antigen, 
would be able to induce T-cell proliferation. For these experiments highly purified PMN 
were cultivated with IL-2 for 24 hours and then cocultivated with highly purified isolated T-
cells in the absence or presence of Staphylococcus enterotoxin A (SEA), a well-known 
superantigen. 
It was imperative to rule out the participation of professional antigen presenting cells, such 
as dendritic cell, monocytes or B-cells. Therefore great care was taken for purification of the 
cells, which was controlled cytofluorometry. Using this method, less than 1% contaminating 
cells could be detected in either the PMN or the T-cell preparation. 
In a first set of experiments PMN in various numbers and for comparison monocytes were 
cocultivated with the T-cells and SEA and proliferation of T-cells was measured after 4 days. 
The experiment showed that about 10 times more PMN than monocytes were required to 
achieve comparable proliferation and that 100 monocytes were barely sufficient to induce T-
cell proliferation above controls (T-cells alone or T-cells with SEA without PMN or 
monocytes, respectively) (Fig. 9). 
 
 
 
 
Fig. 9. Cells were cocultured with PMN or monocytes in the numbers indicated and in the 
presence of SEA. After 4 days proliferation of T-cells was measured by incorporation of [3H] 
–thymidine, where proliferation was seen with at least 100 monocytes or 1000 PMN.  
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Based on the initial experiments, in the following 1000 PMN were used, because this would 
rule out participation of monocytes assuming a 1% contamination.  
We could show that the T-cell proliferation was dependent not only on the number of PMN, 
but also on the presence or absence of SEA, and also dependent on the prestimulation of the 
PMN (Fig. 10). 
 
 
 
 
 
 
 
 
 
 
 
Fig. 10. Effects of bacterial Superantigens SEA on the proliferation of T-cells  cocultured with 
1 x 103 PMN stimulated with IL-2. 
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Moreover, the T-cell proliferation could – at least to some extent – be inhibited, when the 
PMN had been cultivated with IL-2 in the presence of an antibody to the IL-2 receptor  
(Fig. 11). 
 
Fig. 11. Inhibition effect of anti-IL-2R on the proliferation of T-cells cocultured with 1 x 103 
PMN stimulated with IL-2 and bacterial superantigens SEA. 
The above data indicated that a high level of IL-2 in our body increases immunity by its 
effect on PMN to act as antigen presenting cells by the expression of HLA class II and 
consequently increased T-cells proliferation (cell mediated immunity).  
The differences between the groups in the sets of experiments related to the interaction of 
HLA class II positive PMN with peripheral T-cells were calculated by t-test using p < 0.05 as 
limit. 
4. Discussion 
PMN are important effectors cells in host defense and inflammation. They are considered 
short-lived cells undergoing spontaneous apoptosis in vivo as well as in culture (Savill, 
1997). In recent years it has become increasingly evident that culturing PMN in the presence 
of cytokines extends their life span (Colotta et al., 1992; Klebanoff et al., 1992; Lee et al., 1993; 
Biffl et al., 1996). 
Previous data by others suggested that PMN express a receptor for IL-2. The present study 
confirms these data and provides evidence that PMN express constitutively IL-2R. As 
shown for monocytes and NK cells only the IL-2R chain is expressed, but not IL-R 
(Espinoza-Delgado et al., 1990). This was in accordance with the present 
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immunofluorosence results, where we detected only Il-2R chain on resting PMN and 
confirmed my choosing of IL-2 as an activator of PMN. 
Increasing evidence suggests that human PMN have an important role to play in regulating 
specific immune responses and in antigen presentation (Fanger et al., 1997; Radsak et al., 
2000). In this study we have demonstrated that HLA Class II antigen was also detected, at 
the protein level by cytofowmetry, and also at the gene level by RT-PCR. These observations 
therefore agree well with the findings of others who have detected these antigens on the 
surface of activated neutrophils (Matsumoto et al., 1987; Radsak et al., 2000). The detection 
of these molecules therefore provides strong support for the hypothesis that human PMN 
can actively synthesize immunoregulatory molecules (Newburger et al., 2000) and have the 
potential to act as APCs (Fanger et al., 1997; Radsak et al., 2000). The observation that PMN 
may also express HLA class II antigens when appropriately stimulated (Gosselin et al., 1993 
and Fanger et al., 1997), high lighted the possibility that PMN might function as accessory 
cells for T-cell activation. HLA class II expression was found on PMN of patients with active 
Wegener's disease (Haensch, et al., 1999). The close correlation of HLA class II expression to 
disease activity prompted the present study with the objective of investigating whether or 
not HLA class II-positive PMN might activate or support activation of T lymphocytes. 
Induction of the above membrane-bound molecules was higher when PMN were stimulated 
in whole blood. The explanation of this phenomena may be due to the loss of some PMN IL-
2R and IL-15R and other activities during their isolation procedure. 
The absence or low detection of MHC class II on human PMN stimulated with IL-2, IL-4 and 
IL-15 could be due to: 1) The relatively long time (44 hrs) required for class II induction, 
which is beyond the period of PMN survival in most culture systems.  2) IL-2 and IL-15 
receptor numbers may vary with the individual. 3) Synthetic capacity of the PMN may vary. 
4) The capacities of cytokine receptors to signal may not be the same. 5) It may also be 
possible that the PMN themselves produce factors that inhibit class II induction. 6) Synthetic 
capacity of the PMN may vary. 7) The capacities of cytokine receptors to signal may not be 
the same. 8) It may also be possible that the PMN themselves produce factors that inhibit 
class II induction (Gosselin et al., 1993). 
When comparing the number of monocytes and PMN required inducing T-cell proliferation, 
it was observed that 10 times more PMN than monocytes were necessary to yield the same 
extent of T-cell proliferation. However, the cell preparation used in this work never 
contained more than 1% of contaminating cells and certainly not the 10% of monocytes that 
would be required to affect the results. The observation that ten times more PMN than 
monocytes were required to induce a similar extent of T-cell proliferation has to be 
considered together with the observation that only a proportion of PMN acquired HLA class 
II. Thus, when only fully equipped PMN are considered, the ability to process and to 
present antigen is similar to that of monocytes. Whether HLA class II-positive PMN 
participate in the immune defense or play a role in pathophysiological events, is a matter of 
speculation. The fact that only a minor proportion of PMN acquire HLA class II might lead 
to the conclusion that a possible accessory function of PMN would be rather weak. One has, 
however, to bear in mind that PMN are numerous in the peripheral blood, and that even a 
low percentage of PMN expressing HLA class II would exceed both circulating monocytes 
and dendritic cells in number. 
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Because of the notion that the presence of Staphylococcus entrotoxin coincides with relapses of 
Wagner's granulomatosis (Cohn-Terveart et al., 1999), we tested whether PMN was able to 
also present Staphylococcus enterotoxin A  is a superantigen, so-called because it binds outside 
of the peptide-binding groove of the HLA class II and the antigen-specific domain of the T-
cell receptor, and consequently activates a large portion of T-cells, preferentially those with 
a V beta 2 domain (Simpson et al., 1995). In accordance with previous studies (Fanger et al., 
1997; Radsak et al., 2000), co-culture of PMN with T-cells and SE resulted in T-cell 
proliferation. Taken together, our data demonstrate that by synthesizing and expressing of 
HLA class II antigens, PMN acquire the capacity to present superantigens to T-cells. 
5. Conclusion 
In conclusion, PMN possession of IL-2R ǃ and Ǆ chains that have the ability to bind with IL-
2, IL-4 and IL-15 prompted us to use IL-2, IL-4 and IL-15 as stimuli for PMN. They 
stimulated PMN to express HLA class II which is the main antigen presenting molecules. 
PMN expressed HLA class II present SEA to T-cells causing their proliferation. T-cells 
proliferations lead to antigen destruction, B-cells activation and consequently 
immunoglobulin production, and activation of phagocytic cells. 
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